Skip to content Learn about the access keys available for Aristotle.Cloud
This item has been superseded by a newer version by one or more Registration Authorities.

Definition

Incidence of selected cancers of public health importance

Indicator Summary

Numerator

For melanoma, bowel and lung cancer: Number of new cases in the reported year

For cervical and breast cancer in females: Number of new cases in women in the reported year

See more

Denominator

For melanoma, bowel and lung cancer: Total population

For cervical and breast cancer in females: Total female population
See more
Computation

Rates directly age-standardised.

Remoteness and SEIFA Index of Relative Socio-economic Disadvantage (IRSD) are based on postcode of residential address at the time of diagnosis.

Presented as a number and per 100,000.

See more
Disaggregation

2007—Nationally (for each cancer type), by SEIFA Index of Relative Socio-economic Disadvantage (IRSD) deciles

2007—State and territory (for each cancer type), by:

  • Indigenous status
  • remoteness
  • SEIFA IRSD quintiles

Disaggregations within individual states/territories is subject to data quality considerations. Some disaggregations could result in numbers too small for publication. National disaggregation by Indigenous status will be based on jurisidictions with adequate data quality.

See more

Calculation rules

Computation Rule
Description

Rates directly age-standardised.

Remoteness and SEIFA Index of Relative Socio-economic Disadvantage (IRSD) are based on postcode of residential address at the time of diagnosis.

Presented as a number and per 100,000.

Numerators

For melanoma, bowel and lung cancer: Number of new cases in the reported year

For cervical and breast cancer in females: Number of new cases in women in the reported year

Denominators

For melanoma, bowel and lung cancer: Total population

For cervical and breast cancer in females: Total female population
Disaggregation

2007—Nationally (for each cancer type), by SEIFA Index of Relative Socio-economic Disadvantage (IRSD) deciles

2007—State and territory (for each cancer type), by:

  • Indigenous status
  • remoteness
  • SEIFA IRSD quintiles

Disaggregations within individual states/territories is subject to data quality considerations. Some disaggregations could result in numbers too small for publication. National disaggregation by Indigenous status will be based on jurisidictions with adequate data quality.

References

Related content

Relation Count
Indicator Sets that include this Indicator 0
Data Sets that are used in this Indicator 0